DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / The Column Group
The Column Group
Multi-stage venture firmSan Francisco, CAthecolumngroup.comSEC venture capital fund adviserfundraising evidenceone firm, 2 filing advisers
This firm files as 2 advisers on thecolumngroup.com: TCG Labs. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
The Column Group (TCG) is a venture ecosystem dedicated to fueling scientific innovation in the life sciences industry.
both early and growth/opportunity families, reported GAV $4,215M
Importance
70
high
Active deployment
90
high
Emerging
0
low
Completeness
75
high
Freshness
100
high
Research priority
31
moderate
Identity and regulatory footprint
- Headquarters
- San Francisco, CAadviserinfo.sec.gov
- Office address
- ONE LETTERMAN DRIVE, BUILDING D, SUITE M-900, San Francisco, CA, 94129-1492adviserinfo.sec.gov
- Business phone
- 415-865-2050adviserinfo.sec.gov
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 19, 2026
- Private funds reported
- 15 (15 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $3.3Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- The Column Group, LLC (General Partner), NA
- business email
- info@thecolumngroup.comthecolumngroup.compublished by the subject
- business phone
- 415-865-2050adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
39 observed deals
Stated (the firm’s website)
- Sectors
- biotech
- Stages
- early
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 77%Biotechnology 19%Other 3%
lead rate n/afollow-on rate n/anew logos, 12 months 39
Funds and vehicles
15 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Column Group-Neuro II, LP | Fund | 2024 form d first sale | Early deployment | unknown | unknown | $100M of $100M | Feb 13, 2024 |
| The Column Group Opportunity III LP | Opportunity fund | 2022 form d first sale | Active deployment | $652M Mar 20, 2024 | 107 | $600M of $600M | Jun 16, 2022 |
| The Column Group V LP | Fund | 2022 form d first sale | Active deployment | $592M Mar 20, 2024 | 106 | $600M of $600M | Jun 16, 2022 |
| The Column Group Spv I, LP | SPV or co-invest vehicle | 2022 form d first sale | Active deployment | $10.4M Mar 20, 2024 | 2 | $10.5M of $10.5M | Dec 8, 2022 |
| The Column Group - Neuro, LP | Fund | 2021 form d first sale | Mature | $99.9M Mar 20, 2024 | 8 | $100M of $100M | May 14, 2021 |
| The Column Group IV, LP | Fund | 2020 adv first reported | Mature | $1.1B Mar 20, 2024 | 92 | $0 of $700M | Dec 11, 2019 |
| The Column Group Iva LP | Feeder or parallel | 2020 adv first reported | Mature | $32.5M Mar 20, 2024 | 3 | $0 of $25.0M | Dec 11, 2019 |
| Ponoi Capital II, LP | Fund | 2019 adv first reported | Mature | $385M Mar 20, 2024 | 23 | $0 of $100M | Mar 6, 2018 |
| Ponoi Capital LP | Fund | 2017 adv first reported | Harvest | $434M Mar 20, 2024 | 35 | $0 of $150M | Jun 7, 2017 |
| The Column Group Iiia, LP | Feeder or parallel | 2016 form d first sale | Harvest | $180M Mar 20, 2024 | 41 | $271M of $271M | Apr 27, 2016 |
| The Column Group III, LP | Fund | 2016 form d first sale | Harvest | $160M Mar 20, 2024 | 51 | $240M of $240M | Apr 27, 2016 |
| The Column Group II, LP | Fund | 2010 form d first sale | Harvest | $232M Mar 20, 2024 | 64 | $65.5M of $350M | Mar 10, 2010 |
| The Column Group, LP | Fund | unknown | Unknown | $377M Mar 20, 2024 | 63 | unknown | unknown |
| Column Group VI, LP | Fund | unknown | Fundraising | unknown | unknown | $0 of $600M | Dec 16, 2025 |
| Column Group Opportunity IV, LP | Opportunity fund | unknown | Fundraising | unknown | unknown | $0 of $600M | Dec 16, 2025 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
36 current, 5 departed
Koning Shen
AssociateAssociate
David van Norman Goeddel
Managing partnerManaging Partner · since Mar 1, 2005
Peter Haqvin Erland Svennilson
Managing partnerManaging Partner · since Mar 1, 2005
Peter Haqvin Erland Svennilson
Managing partnerManaging Partner · since Mar 1, 2005
Peter Svennilson
Managing partnerFounder / Managing Partner
Tim Kutzkey
Managing partnerManaging Partner
Timothy William Kutzkey
Managing partnerManaging Partner · since Sep 1, 2016
Timothy William Kutzkey
Managing partnerManaging Partner · since Sep 1, 2016
Charles Sawyers
PartnerScience Partner
Charles Zuker
PartnerScience Partner
David V. Goeddel
PartnerPartner Emeritus
Helen Hobbs
PartnerScience Partner
Huda Y. Zoghbi
PartnerScience Partner
Hui Tian
PartnerPartner
Jeff Goater
PartnerPartner
John Josey
PartnerPartner
K. Chris Garcia
PartnerScience Partner
Leon Chen
PartnerPartner
Michael Fischbach
PartnerScience Partner
Robert Tjian
PartnerDiscovery Partner
Roger Perlmutter
PartnerScience Partner
Sarah Hymowitz
PartnerPartner
Alyssa Liu
Platform and operationsSenior Accounting Manager
Carla Daniel
Platform and operationsPartner & Chief People Officer
David Liu
Platform and operationsDirector of Accounting
James Evangelista
Platform and operationsPartner & Chief Financial Officer
James Philip Evangelista
Platform and operationsChief Financial Officer · since Jun 1, 2012
James Philip Evangelista
Platform and operationsChief Financial Officer · since Jun 1, 2012
Kristen Steele Hunter
Platform and operationsDirector, Portfolio Finance & Operations
Nathan Levy
Platform and operationsDirector of Tax/Finance
Shannon Stone
Platform and operationsDirector of Portfolio Talent
Karina Tin
PrincipalDirector of Administration & Technology
Andrew C. Chan
Venture partnerVenture Partner
Arnav Mehta
Venture partnerVenture Partner
Craig Parker
Venture partnerVenture Partner
Matt Callahan
Vice presidentSenior Associate
5 departed (kept with end dates)
- Harald Jan Michael Ekman · Limited Partner Of Fund Gp Spv Only · Oct 1, 2012 to Mar 20, 2013 Inference
- Eikon Therapeutics · Science Partner · ? to Sep 16, 2026 Inference
- Kevin Moses · Partner · Sep 1, 2016 to May 8, 2017 Inference
- Laurence a. Lasky · Partner (The Column Group Management Lp) · May 1, 2014 to Jan 15, 2020 Inference
- Robert Tjian · Discovery Partner (Ponoi Management, Llc) · Jun 1, 2017 to Mar 29, 2019 Inference
Investments on record
39 edges, 31 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
15 relationships from shared deals, counted for the whole firm
Springrock Management 2 shared · recurringDecheng Capital LLC 1 shared · one timeAvoro Capital Advisors LLC 1 shared · one timeNavimed Capital Advisors, LLC 1 shared · one timeAmoon Ventures Y.SH. Ltd. 1 shared · one timeOmega Fund Management, LLC 1 shared · one timeLUX Capital Management, LLC 1 shared · one timeRA Capital Management, LP 1 shared · one timeLifeforce Capital Management, LLC 1 shared · one timeCRV, LLC 1 shared · one timeCity Hill Ventures, LLC 1 shared · one timeMtech Capital 1 shared · one timeIaso Ventures Management Firm LLC 1 shared · one timeMission Biocapital 1 shared · one timeProspect Management Co. II, LLC 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
23 dated events
- Sep 16, 2026Johnson and Johnson no longer listed on The Column Group's portfolio pageRemoved from portfolio pagePortfolioInferenceJohnson and JohnsonVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Eikon Therapeutics (Science Partner) no longer on the team page of The Column GroupPerson leftPeopleInferenceEikon TherapeuticsVenture organization websites (about, team, portfolio, thesis, news pages)
- Mar 17, 2023The Column Group V LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $608,034,807Fund first reported on Form ADVFundsFactThe Column Group V LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 17, 2023The Column Group Spv I, LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $10,396,044Fund first reported on Form ADVFundsFactThe Column Group Spv I, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 17, 2023The Column Group Opportunity III LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $602,428,062Fund first reported on Form ADVFundsFactThe Column Group Opportunity III LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2022The Column Group - Neuro, LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $99,803,372Fund first reported on Form ADVFundsFactThe Column Group - Neuro, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 27, 2020The Column Group Iva LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $17,929,292Fund first reported on Form ADVFundsFactThe Column Group Iva LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 27, 2020The Column Group IV, LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $707,070,707Fund first reported on Form ADVFundsFactThe Column Group IV, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 15, 2020Laurence a. Lasky (Partner (The Column Group Management Lp)) no longer on Schedule A of The Column Group
- Mar 29, 2019Ponoi Capital II, LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $154,572,491Fund first reported on Form ADVFundsFactPonoi Capital II, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2019Robert Tjian (Discovery Partner (Ponoi Management, Llc)) no longer on Schedule A of The Column Group
- Jul 20, 2017Ponoi Capital LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $175,000,000Fund first reported on Form ADVFundsFactPonoi Capital LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- May 8, 2017Kevin Moses (Partner) no longer on Schedule A of The Column Group
- Mar 28, 2017The Column Group III, LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $247,641,211Fund first reported on Form ADVFundsFactThe Column Group III, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 28, 2017The Column Group Iiia, LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $279,674,070Fund first reported on Form ADVFundsFactThe Column Group Iiia, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Sep 1, 2016Robert Tjian joined Schedule A of The Column Group as Discovery Partner (The Column Group Iii Management Lp)
- Sep 1, 2016Kevin Moses joined Schedule A of The Column Group as Partner
- May 6, 2014The Column Group II, LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $206,641,000Fund first reported on Form ADVFundsFactThe Column Group II, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- May 1, 2014Laurence a. Lasky joined Schedule A of The Column Group as Partner, The Column Group Ii Management Lp
- Mar 20, 2013Harald Jan Michael Ekman (Limited Partner Of Fund Gp Spv Only) no longer on Schedule A of The Column Group
- Jun 1, 2012James Philip Evangelista joined Schedule A of The Column Group as Director Of Finance
- Mar 30, 2012The Column Group first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012The Column Group, LP first reported on Form ADV by The Column Group (Venture Capital Fund), GAV $238,545,544Fund first reported on Form ADVFundsFactThe Column Group, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 15, 2026Multi-stage venture firm (confirmed, 95%, cls-1)both early and growth/opportunity families, reported GAV $4,215M
- Sep 12, 2026Multi-stage venture firm (confirmed, 95%, cls-1)both early and growth/opportunity families, reported GAV $3,838M
Evidence
64 observations from 4 sources